Detalhe da pesquisa
1.
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
JAMA
; 330(4): 328-339, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428480
2.
Elevated inflammatory markers are associated with poor outcomes in COVID-19 patients treated with remdesivir.
J Med Virol
; 94(1): 384-387, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406670
3.
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.
medRxiv
; 2022 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172138